West Pharmaceutical Services (WST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2003 | 03-2003 | 12-2002 | 09-2002 | 06-2002 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 44,300 | 37,100 | 33,200 | 35,700 | 28,000 |
| Receivables | 83,400 | 75,600 | 70,200 | 66,700 | 74,100 |
| Inventories | 45,000 | 42,400 | 41,300 | 40,400 | 40,400 |
| Income taxes - deferred | 5,300 | 5,100 | 5,200 | 2,700 | 2,400 |
| Other current assets | 11,300 | 12,300 | 11,900 | 9,200 | 8,600 |
| TOTAL | $189,300 | $172,500 | $161,800 | $154,700 | $153,500 |
| Non-Current Assets | |||||
| PPE Net | 222,100 | 213,700 | 223,300 | 217,300 | 222,500 |
| Investments And Advances | 19,500 | 18,900 | 18,000 | 18,900 | 19,800 |
| Intangibles | 47,100 | 45,200 | 42,800 | 42,800 | 43,400 |
| Other Non-Current Assets | 89,400 | 91,600 | 83,700 | 82,700 | 85,900 |
| TOTAL | $378,100 | $369,400 | $367,800 | $361,700 | $371,600 |
| Total Assets | $567,400 | $541,900 | $529,600 | $516,400 | $525,100 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 11,800 | 11,400 | 11,700 | 500 | 6,600 |
| Accounts payable and accrued liabilities | 21,900 | 21,600 | 19,200 | 19,700 | 20,400 |
| Accrued Expenses | 61,700 | 58,200 | 53,200 | 49,300 | 49,800 |
| TOTAL | $99,100 | $92,700 | $88,200 | $75,100 | $83,500 |
| Non-Current Liabilities | |||||
| Long Term Debt | 164,100 | 160,700 | 159,200 | 172,000 | 172,000 |
| aiOther Non-Current Liabilities | 32,800 | 32,600 | 32,200 | 27,700 | 28,100 |
| TOTAL | $246,600 | $242,200 | $239,900 | $247,600 | $247,800 |
| Total Liabilities | $345,700 | $334,900 | $328,100 | $322,700 | $331,300 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 57,978 | 57,918 | 57,952 | 57,855 | 57,848 |
| Common Shares | 4,300 | 4,300 | 4,300 | 4,300 | 4,300 |
| Retained earnings | 266,100 | 262,100 | 261,200 | 260,600 | 259,900 |
| Other shareholders' equity | 1,400 | -8,300 | -12,900 | -20,400 | -19,600 |
| TOTAL | $221,700 | $207,000 | $201,500 | $193,700 | $193,800 |
| Total Liabilities And Equity | $567,400 | $541,900 | $529,600 | $516,400 | $525,100 |